ULTIMED ANNOUNCES PRIVATE LABEL LANCETS

ST. PAUL, MINNESOTA – February 17, 2005 – UltiMed has added lancets to its innovative private label line which features insulin syringes and pen needles in the traditional packaging style. Private label insulin syringes are also available in UltiMed’s dual-purpose UltiGuard packaging style. UltiMed’s private label syringes, pen needles and lancets offer retailers a unique solution to increase penetration rates and contribution margins.

UltiMed, Inc. which is headquartered in St. Paul, Minnesota markets syringes, needles, pen needles, lancets and innovative dual-purpose sharps containers for both the domestic and international markets. The Company owns and operates state of the art medical device manufacturing facilities in the U.S. and abroad. UltiMed also has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

UltiMed Inc., 287 East 6th Street, St. Paul, MN 55101 www.ulti-care.com